Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1

This publication has 31 references indexed in Scilit:

• Preeclampsia, a Disease of the Maternal Endothelium
  Circulation, 2011
• Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension
  Circulation, 2010
• Preeclamptic placental stress and over expression of mitochondrial HSP70
  Clinical Chemistry and Laboratory Medicine (CCLM), 2009
• Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
  New England Journal of Medicine, 2006
• In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease
  Hypertension, 2005
• Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
  The Journal of Maternal-Fetal & Neonatal Medicine, 2005
• Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
  Clinical Chemistry, 2004
• Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia
  American Journal of Obstetrics and Gynecology, 2004
• Placental Superoxide is Increased in Pre-eclampsia
  Placenta, 2001
• Placental mitochondria as a source of oxidative stress in pre-eclampsia
  Placenta, 1998